Join SIO for the second annual NEXT Summit: Novel Explorations in Combination Therapies, taking place 28–29 May 2026 at the Gleacher Center in Chicago.

Experience a one-of-a-kind educational program that delivers cutting-edge, clinically integrated insights, spotlighting the latest advances in combination therapies and an expanded range of organ-specific content. Designed in collaboration with SITC and AASLD, the NEXT Summit offers a dynamic, multidisciplinary environment where attendees can explore breakthrough therapeutic innovations and emerging immunotherapy strategies.

The 2026 NEXT Summit program broadens its focus beyond HCC and liver cancers to include additional disease states, integrating novel therapeutic applications and next-generation combination approaches that reflect the rapidly evolving landscape of patient care and drive forward-thinking treatment strategies.

Register Today

Learning Objectives

• Critically evaluate landmark clinical trial data from 2025–2026 and translate these findings into forward-looking strategies that shape patient care.
• Apply emerging evidence in combination and sequencing approaches to optimize IO and systemic treatment regimens across disease stages.
• Leverage cross-disciplinary insights from an unprecedented AASLD–SITC collaboration to integrate hepatology, immuno-oncology, and interventional oncology perspectives into clinical decision-making.
• Engage in a highly interactive, collaborative format that catalyzes innovation, accelerates partnerships, and drives real-world implementation of new therapeutic approaches.
• Connect directly with clinical leaders and innovators to inform practice change and influence the next generation of therapy development.

 

Thank You to Our Next Summit Sponsors